Genetic and/or epigenetic defects determining a partial deficiency of Gsα lead to resistance to the action of the PTH hormone, which is the hallmark of pseudohypoparathyroidism (PHP), and the alteration of the PTH/PTHrP-Gsα-cAMP signaling pathway (11–16). This evidence concerns the gene PTH and pseudohypoparathyroidism.